In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Taisho Toyama Pharmaceutical Co. Ltd.

Division of Taisho Pharmaceutical Co. Ltd.

Latest From Taisho Toyama Pharmaceutical Co. Ltd.

PIPELINE WATCH: Three Approvals, Three Filings And Two Launches

This week's Pipeline Watch, a snapshot of all the late-stage R&D and regulatory events in the pharma and biotech industries, is now available to view.

Research & Development Pipeline Watch

Approval Clears Way For Evolocumab To Blaze Japan PCSK9 Trail

Following a positive recommendation late last year, Japan has now issued a formal regulatory approval to Amgen Astellas’s evolocumab, which will blaze a trail as the first PCSK9-targeting biologic to be commercialized in the country.

BioPharmaceutical Japan

Asia On The Move: Roche Hires Bayer Executive As China GM

April brings showers and executive changes, with a flurry of personnel activity at Amgen, Bayer and Roche in China.

BioPharmaceutical China

Deals Shaping The Medical Industry, January 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Pharmaceuticals, and Medical Devices – and then categorized by type –Acquisition, Alliance, or Financing.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Taisho Pharmaceutical Co. Ltd.
  • Senior Management
  • Akira Ohira, Pres.
  • Contact Info
  • Taisho Toyama Pharmaceutical Co. Ltd.
    25-1 Takeda 3-Chrome